These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2916562)

  • 1. Splenic irradiation as primary therapy for prolymphocytic leukemia.
    Kiss A; Haubenstock A; Bognar H; Scheiderbauer R; al-Mobarak M; Base W
    Am J Hematol; 1989 Mar; 30(3):188-9. PubMed ID: 2916562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic irradiation for prolymphocytic leukemia: is it preferable as an initial treatment or not?
    Yamamoto K; Hamaguchi H; Nagata K; Shibuya H; Takeuchi H
    Jpn J Clin Oncol; 1998 Apr; 28(4):267-9. PubMed ID: 9657013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic irradiation as primary therapy for prolymphocytic leukaemia.
    Muncunill J; Villá S; Domingo A; Doménech P; Arnaiz MD; Callis M
    Br J Haematol; 1990 Oct; 76(2):305-6. PubMed ID: 2094335
    [No Abstract]   [Full Text] [Related]  

  • 4. Splenic irradiation as initial therapy for prolymphocytic leukemia.
    Aggio MC
    Eur J Haematol; 1992 Jul; 49(1):46-7. PubMed ID: 1499697
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders.
    Weinmann M; Becker G; Einsele H; Bamberg M
    Radiother Oncol; 2001 Mar; 58(3):235-46. PubMed ID: 11230883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolymphocytic leukemia: the therapeutic strategy].
    Fava S; De Paoli A; Grimi E; Luoni M; Tocci A; Tosi A; Cassi E
    Recenti Prog Med; 1994 Oct; 85(10):496-501. PubMed ID: 7809465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment options in prolymphocytic leukemia.
    Robak T; Robak P
    Med Sci Monit; 2007 Apr; 13(4):RA69-80. PubMed ID: 17392661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course.
    Shvidel L; Shtalrid M; Bassous L; Klepfish A; Vorst E; Berrebi A
    Leuk Lymphoma; 1999 Mar; 33(1-2):169-79. PubMed ID: 10194135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic irradiation in B-prolymphocytic leukaemia.
    Oscier DG; Catovsky D; Errington RD; Goolden AW; Roberts PD; Galton DA
    Br J Haematol; 1981 Aug; 48(4):577-84. PubMed ID: 6974001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Splenic irradiation as a successful treatment for an elderly patient with B-cell prolymphocytic leukemia].
    Nakashima H; Saito B; Ariizumi H; Matsuda I; Nakamaki T; Tomoyasu S
    Rinsho Ketsueki; 2008 Dec; 49(12):1619-22. PubMed ID: 19110524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary study of low-dose splenic irradiation for the treatment of chronic lymphocytic and prolymphocytic leukaemias.
    Singh AK; Bates T; Wetherley-Mein G
    Scand J Haematol; 1986 Jul; 37(1):50-8. PubMed ID: 3489979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolymphocytic leukemia.
    Stone RM
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):457-71. PubMed ID: 2182602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolymphocytic leukemia: a very satisfactory response to treatment with recombinant interferon alpha.
    Vivaldi P; Garuti R; Rubertelli M; Mazzon C
    Haematologica; 1992; 77(2):169-70. PubMed ID: 1398302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained response of refractory prolymphocytic leukemia to fludarabine.
    Sporn JR
    Acta Haematol; 1991; 85(4):209-11. PubMed ID: 1853684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell prolymphocytic leukemia with a novel translocation (6;11)(q21;q23).
    Wong KF; Chan JK; Sin VC
    Cancer Genet Cytogenet; 1999 Jun; 111(2):149-51. PubMed ID: 10347553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of prolymphocytic leukemia.
    Hollister D; Coleman M
    Cancer; 1982 Nov; 50(9):1687-9. PubMed ID: 6956431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolymphocytic B-cell leukemia with fatal acute liver failure. A case report].
    Steidl L; Rossi A; Cornaggia M; Crippa G; Venco A
    Recenti Prog Med; 1994 Mar; 85(3):186-9. PubMed ID: 8184202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous localization of T-cell prolymphocytic leukemia].
    Thomas A; Dompmartin A; Troussard X; Moreau A; Manard C; Leroy D
    Ann Dermatol Venereol; 1995; 122(8):526-9. PubMed ID: 8572493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia.
    Saven A; Lee T; Schlutz M; Jacobs A; Ellison D; Longmire R; Piro L
    J Clin Oncol; 1997 Jan; 15(1):37-43. PubMed ID: 8996122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia.
    Brito-Babapulle V; Pittman S; Melo JV; Pomfret M; Catovsky D
    Hematol Pathol; 1987; 1(1):27-33. PubMed ID: 3509770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.